Zusammenfassung
Phospholipide gehören zur Familie der Membranlipide und bilden den Hauptbestandteil der zellulären Doppelmembran. Ihre spezifischen physikochemischen Eigenschaften erhalten sie durch einen hydrophilen Kopf- und einen lipophilen Schwanzteil. In den enzymatischen Gerinnungsreaktionen fungieren Phospholipide als reaktive Oberflächen und ermöglichen die Ausbildung der Multienzymkomplexe. Eine gestörte Interaktion einzelner Gerinnungsfaktoren mit Phospholipiden kann den Gerinnungsprozess inhibieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Atsumi T, Koike T (2002) Clinical Relevance of antiprothrombin antibodies. Autoimmun Rev 1: 49–53
Atsumi T, Ieko M, Bertolaccini ML et al. (2000) Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43(9): 1982–1993
Bizzaro N, Antico A, Musso M et al. (2005a). A prospective study of 1038 pregnancies on the predictive value of anti-Annexin V antibodies for fetal loss. Ann NY Acad Sci 1050: 348–356
Bizzaro N, Tonutti E, Villalta D et al. (2005b) Prevalence and clinical correlation of anti-phospholipid binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 129(1): 61–68
Conrad K, Schößler W, Hiepe F (2007) Autoantikörper bei systemischen Autoimmunerkrankungen. Pabst Science Publishers, Lengerich
Di Simone N, Castellani R, Caliandro D et al. (2001) Monoclonal anti-Annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 65: 1766–1770
Galli M, Comfurius P, Maassen C et al. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544–1547
Harris EN, Gharavi AE, Boey ML et al. (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2: 1211–1215
Hasegawa M, Sato S, Yanaba K et al. (2004) Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis. Ann Rheum Dis 63: 1514–1517
Hunt JE, Krilis SA (1994) The fifth domain of β2-glycoprotein I contains a phopholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 152: 653–659
IUPAC (1977) The nomenclature of lipids (recommendations 1976), IUPAC-IUB-Commission on Biochemical Nomenclature. Europ J Bioche. 79: 11–21
Kaburaki J, Kuwana M, Yamamoto M et al. (1997) Clinical significance of anti-annexin V antibodies in patients with systemic Lupus erythematosus. Am J Hematol 54: 209–213
Koike T (1994) Anticardiolipin antibodies and β2-glycoprotein I. Clin Immunol Immunpathol 72(2): 187–192
Koike T, Ichikawa K, Kasahara H et al. (1998) Epitopes on beta2-GPI recognized by anticardiolipin antibodies. Lupus 7(Suppl.2): 14–17
Levy RA, Gharavi AE, Sammaritano LR (1990) Fatty acid chain is a critical epitope for antiphospholipid antibody. J Clin Immunol 13(3): 141–145
Lölinger A (1959) Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematodes? Thromb Diath Haemorrh 3: 237–256
Loizou S, McRea JD, Rudge AC et al. (1985) Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62: 738–745
Matsuura ER, Igarashi Y, Fujimoto M et al. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177–178
Matsuura ER, Igarashi Y, Yasuda T et al. (1994) Anticardiolipin antibodies recognise β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179: 457–462
McNeil HP, Simpson RF, Chesterman CN et al. (1990). Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120–4124
Nojima J, Kuratsune H, Snehisa E et al. (2001) Association between the prevalence of antibodies to β2-glycoprotein I, prothrombin, protein C, protein S and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47: 1008–1015
Rand JH, Wu X-X (2001) Antiphospholipid antibody-mediated interference with annexin-V anticoagulant activity. Hämostaseologie 21: 50–53
Rand JH, Wu X-X (2004) Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thromb Res 114: 383–389
Rauch J, Tannenbaum M, Janoff S (1989) Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemostas 62(3): 892–896
Roubey RAS, Eisenberg RA, Winfield JB (1994) Autoantibodies to β2-glycoprotein I: the role of antibody affinity and antigen density. Lupus 3: 314
Stryer L (1991) Biochemie. Spektrum Akad. Verlag, Heidelberg, S 307
Triplett DA (1992) Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 28: 211–215
von Landenberg P, Matthias T, Zaech J et al. (2003) Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 49: 51–56
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schößler, W. (2010). Phospholipide und phospholipidbindende Proteine. In: Pötzsch, B., Madlener, K. (eds) Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01544-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-01544-1_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01543-4
Online ISBN: 978-3-642-01544-1
eBook Packages: Medicine (German Language)